Testing effectiveness (Phase 2)Study completedNCT00845429
What this trial is testing
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects
Who this might be right for
InfluenzaOrthomyxovirusesMyxovirus Infection
Sanofi 729